FDCDDQ
DOVA

Federation des caisses Desjardins du Quebec’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-180
Closed -$5.39K – 2218
2018
Q2 		$5.39K Buy
+180
New +$4.9K ﹤0.01% 1885

Other funds holding DOVA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's DOVA Position: Q3 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2018, closing a stake of 180 shares — an estimated $5.39K sold.

Federation des caisses Desjardins du Quebec first reported a position in DOVA in Q2 2018 and held it in 1 quarter. The position peaked at $5.39K in Q2 2018. 63 funds tracked by Wall St. Rank hold DOVA as of Q3 2018.

  • Federation des caisses Desjardins du Quebec reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 180 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $5.39K.
  • Federation des caisses Desjardins du Quebec first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Federation des caisses Desjardins du Quebec's Dova Pharmaceuticals, Inc. Common Stock position peaked at $5.39K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2018, filed 30 Aug 2024.